Standout Papers

Prevalence and risk factor for long COVID in children and adolescents: A meta-analysis and systematic review 2023 2026 202467
  1. Prevalence and risk factor for long COVID in children and adolescents: A meta-analysis and systematic review (2023)
    Yongbo Zheng, Na Zeng et al. Journal of Infection and Public Health

Immediate Impact

5 by Nobel laureates 61 standout
Sub-graph 1 of 24

Citing Papers

Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy
2024 Standout
The global prevalence of depression, anxiety, and sleep disorder among patients coping with Post COVID-19 syndrome (long COVID): a systematic review and meta-analysis
2024 Standout
1 intermediate paper

Works of Peipei Shi being referenced

Prevalence and risk factor for long COVID in children and adolescents: A meta-analysis and systematic review
2023 Standout
Treatment Rationale and Study Design for the JUNIPER Study: A Randomized Phase III Study of Abemaciclib With Best Supportive Care Versus Erlotinib With Best Supportive Care in Patients With Stage IV Non–Small-Cell Lung Cancer With a Detectable KRAS Mutation Whose Disease Has Progressed After Platinum-Based Chemotherapy
2015

Author Peers

Author Last Decade Papers Cites
Peipei Shi 108 150 20 86 35 377
Tomáš Kepák 38 102 1 91 30 431
Alejandro Ruíz-Patiño 123 76 135 38 349
Rui Liu 100 168 7 163 41 437
Sandipan Chakraborty 51 104 3 56 29 443
Valentina Nardi 152 68 50 53 40 432
Yufeng Shang 24 122 2 102 29 420
Wei Zhang 52 149 5 70 24 418
Lei Dong 113 134 3 178 54 431
Yanfang Qiu 74 119 79 24 366
Reo Tanoshima 41 82 7 63 39 437

All Works

Loading papers...

Rankless by CCL
2026